Publications

Drug-resistance mechanisms and tuberculosis drugs.

Köser, CU; Javid, B; Liddell, K; Ellington, MJ; Feuerriegel, S; Niemann, S; Brown, NM; Burman, WJ; Abubakar, I; Ismail, NA; MOORE, D; PEACOCK, SJ; Török, ME;

2015

Lancet, (2015).385 9965 10.1016/S0140-6736(14)62450-8.

Brief Report: The Effect of Antiretroviral Therapy and CD4 Count on Markers of Infectiousness in HIV-Associated Tuberculosis.

Van Halsema, CL; FIELDING, KL; Chihota, VN; George, EC; LEWIS, JJ; CHURCHYARD, GJ; GRANT, AD;

2015

Journal of acquired immune deficiency syndromes (1999), (2015).70 1 10.1097/QAI.0000000000000684.

Engaging for-profit providers in TB control: lessons learnt from initiatives in South Asia.

KHAN, MS; Salve, S; PORTER, JD H;

2015

Health policy and planning, (2015).30 10 10.1093/heapol/czu137.

Contribution of Xpert® MTB/RIF to the diagnosis of pulmonary tuberculosis among TB-exposed children in The Gambia.

TOGUN, TO; Egere, U; Sillah, AK; Ayorinde, A; Mendy, F; TIENTCHEU, L; Otu, J; ANTONIO, M; SUTHERLAND, J; Hill, PC; KAMPMANN, B;

2015

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, (2015).19 9 10.5588/ijtld.15.0228.

Advances in the Diagnosis of HIV-Associated Tuberculosis.

GUPTA-WRIGHT, A; LAWN, SD;

2015

EMJ Respi, (2015).3 1

The Second Zambian National Tuberculosis Drug Resistance survey - a comparison of conventional and molecular methods.

Kapata, N; Mbulo, G; Cobelens, F; De Haas, P; SCHAAP, A; Mwamba, P; Mwanza, W; Muvwimi, M; Muyoyeta, M; Moyo, M; Mulenga, L; Grobusch, MP; GODFREY-FAUSSETT, P; AYLES, H;

2015

Tropical medicine & international health, (2015).20 11 10.1111/tmi.12581.

Duration of protection of infant BCG vaccination in Ethnic minority groups in England.

MANGTANI, P; NGUIPDOP-DJOMO, P; KEOGH, R; Abubakar, I; SMITH, PG; RODRIGUES, LC;

2015

46th Union World Conference on Lung Health (2015).

Multi-center evaluation of a user-friendly lateral flow assay to determine IP-10 and CCL4 levels in blood of TB and non-TB cases in Africa.

Corstjens, PL A M; Tjon Kon Fat, EM; De Dood, CJ; Van der Ploeg-van Schip, JJ; Franken, KL M C; Chegou, NN; SUTHERLAND, JS; Howe, R; Mihret, A; Kassa, D; Van der Vyver, M; Sheehama, J; Simukonda, F; Mayanja-Kizza, H; Ottenhoff, TH M; Walzl, G; Geluk, A; AE-TBC consortium,;

2015

Clinical biochemistry, (2015).49 1-2 10.1016/j.clinbiochem.2015.08.013.

The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South Africa.

KNIGHT, GM; Gomez, GB; Dodd, PJ; Dowdy, D; Zwerling, A; Wells, WA; Cobelens, F; VASSALL, A; WHITE, RG;

2015

PloS one, (2015).10 12 10.1371/journal.pone.0145796.

Molecular epidemiology of Mycobacterium tuberculosis among South African gold miners.

Mathema, B; LEWIS, JJ; Connors, J; Chihota, VN; Shashkina, E; Van der Meulen, M; Graviss, EA; Ha, NP; Kreiswirth, BN; GRANT, AD; FIELDING, KL; Dorman, SE; CHURCHYARD, GJ;

2015

Annals of the American Thoracic Society, (2015).12 1 10.1513/AnnalsATS.201404-150OC.